Clinical trial
Performance and Safety of Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate During Continuous Veno-venous Hemodialysis for Sepsis-associated AKI: Protocol for a Phase I-II Randomized Crossover Pilot Study.
NCT07236463 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Performance and Safety of Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate During Continuous Veno-venous Hemodialysis for Sepsis-associated AKI: Protocol for a Phase I-II Randomized Crossover Pilot Study.
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- June 4, 2026
- Completion date
- June 30, 2028
- Enrollment
- 14 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.